KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Amortizatization of Intangibles: 2015-2024

Historic Amortizatization of Intangibles for Supernus Pharmaceuticals (SUPN) over the last 10 years, with Dec 2024 value amounting to -$1.8 million.

  • Supernus Pharmaceuticals' Amortizatization of Intangibles rose 195.34% to $921,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 183.78%. This contributed to the annual value of -$1.8 million for FY2024, which is 1594.26% down from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Amortizatization of Intangibles of -$1.8 million as of FY2024, which was down 1,594.26% from $122,000 recorded in FY2023.
  • In the past 5 years, Supernus Pharmaceuticals' Amortizatization of Intangibles registered a high of $2.9 million during FY2020, and its lowest value of -$3.2 million during FY2022.
  • For the 3-year period, Supernus Pharmaceuticals' Amortizatization of Intangibles averaged around -$1.6 million, with its median value being -$1.8 million (2024).
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first spiked by 103.77% in 2023, then plummeted by 1,594.26% in 2024.
  • Supernus Pharmaceuticals' Amortizatization of Intangibles (Yearly) stood at $2.9 million in 2020, then plummeted by 114.47% to -$418,000 in 2021, then slumped by 673.44% to -$3.2 million in 2022, then spiked by 103.77% to $122,000 in 2023, then tumbled by 1,594.26% to -$1.8 million in 2024.